Nemaura Medical Inc. (NMRD)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 0.0300 |
| Open | 0.0350 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0300 - 0.0350 |
| 52-week range | 0.0290 - 1.2500 |
| Volume | |
| Avg. volume | 44,121 |
| Market cap | 866,982 |
| Beta (5Y monthly) | -0.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Nemaura (NMRD) to Expand in UK With Metabolic Health Program
The latest program leverages Nemaura's (NMRD) world-first daily wear non-invasive CGM technology, providing individuals with real-time insights into their body's glucose dynamics.
- Simply Wall St.
Nemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)
Nemaura Medical ( NASDAQ:NMRD ) First Half 2024 Results Key Financial Results Net loss: US$3.81m (loss narrowed by 52...
- Zacks
Nemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?
Nemaura Medical, Inc. (NMRD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2024 Yahoo. All rights reserved.